PT AVENTIS PHARMA

Business Nature: Manufacturer (It is a pharmaceutical manufacturing company and a subsidiary of the global healthcare company Sanofi).

Company Overview:

PT Aventis Pharma is a prominent pharmaceutical company based in Indonesia. As a key subsidiary of the Sanofi Group, the company focuses on the local manufacturing, marketing, and distribution of high-quality pharmaceutical products. Its operations encompass a wide range of therapeutic areas, including vaccines, diabetes management, cardiovascular health, and consumer healthcare. The company operates a state-of-the-art manufacturing facility in Indonesia that adheres to international Good Manufacturing Practice (GMP) standards to ensure product safety and efficacy for both local and regional markets. Through its commitment to innovation and healthcare accessibility, PT Aventis Pharma plays a significant role in supporting the Indonesian healthcare system.

PT Aventis Pharma, a Sanofi company in Indonesia, manufactures or sells a range of pharmaceutical products across various therapeutic areas. Some of these products include:

Diabetes

Lantus (insulin glargine)

Amaryl (glimepiride)

Toujeo (insulin glargine)

Apidra (insulin glulisine)

Cardiovascular Diseases

Plavix (clopidogrel)

Clexane (enoxaparin)

Multaq (dronedarone)

Vaccines

Hexaxim (DTaP-IPV-Hib-HepB vaccine)

Pentaxim (DTaP-IPV-Hib vaccine)

Vaxigrip Tetra (quadrivalent influenza vaccine)

Typhim Vi (typhoid polysaccharide vaccine)

Act-HIB (Haemophilus influenzae type b vaccine)

Avaxim (Hepatitis A vaccine)

Allergy and Respiratory

Allegra (fexofenadine)

Telfast (fexofenadine)

Gastrointestinal

Buscopan (butylscopolamine bromide)

Other Therapeutic Areas

Solu-Medrol (methylprednisolone)

Depo-Medrol (methylprednisolone acetate)

This list represents a selection of their products and may not be exhaustive.